Objective:

To synthesize the regulatory networks governing post-translational modifications (PTMs) in diabetic kidney disease (DKD) and evaluate emerging therapeutic strategies targeting these modifications.

Approach:

Key Findings:

• Dysregulated PTM networks are central to DKD progression.
• Aberrant phosphorylation patterns in insulin signaling contribute to insulin resistance in DKD.
• Hyperactivation of MAPK pathways due to phosphorylation promotes inflammation and renal injury.
• Dysregulation of the TGF-β/Smad pathway via phosphorylation accelerates renal fibrosis.

Interpretation:

Targeting PTMs may provide new therapeutic avenues for halting DKD progression.

Limitations:

• The review does not provide specific clinical trial data on therapeutic interventions.
• Further research is needed to fully elucidate the role of various PTMs in DKD and their potential as therapeutic targets.

Conclusion:

Investigating PTM regulatory networks is essential for understanding DKD mechanisms and developing targeted therapies.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.